733 related articles for article (PubMed ID: 17466605)
1. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
[TBL] [Abstract][Full Text] [Related]
2. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.
Shao Y; Alluri R; Mummert M; Koetter U; Lech S
J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989
[TBL] [Abstract][Full Text] [Related]
3. A stability-indicating high performance liquid chromatographic assay for the determination of orlistat in capsules.
Mohammadi A; Haririan I; Rezanour N; Ghiasi L; Walker RB
J Chromatogr A; 2006 May; 1116(1-2):153-7. PubMed ID: 16603170
[TBL] [Abstract][Full Text] [Related]
4. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.
Jing Q; Shen Y; Tang Y; Ren F; Yu X; Hou Z
J Pharm Biomed Anal; 2006 Jun; 41(3):1065-9. PubMed ID: 16545536
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms.
Karakuş S; Küçükgüzel I; Küçükgüzel SG
J Pharm Biomed Anal; 2008 Jan; 46(2):295-302. PubMed ID: 18054459
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a stability-indicating analytical method for the quantitation of oxytocin in pharmaceutical dosage forms.
Chaibva FA; Walker RB
J Pharm Biomed Anal; 2007 Jan; 43(1):179-85. PubMed ID: 16920323
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form.
den Brok MW; Nuijen B; Hillebrand MJ; Grieshaber CK; Harvey MD; Beijnen JH
J Pharm Biomed Anal; 2005 Sep; 39(1-2):46-53. PubMed ID: 15899571
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations.
Kyriakides D; Panderi I
Anal Chim Acta; 2007 Feb; 584(1):153-9. PubMed ID: 17386598
[TBL] [Abstract][Full Text] [Related]
9. HPLC separation technique for analysis of bufuralol enantiomers in plasma and pharmaceutical formulations using a vancomycin chiral stationary phase and UV detection.
Hefnawy MM; Sultan MA; Al-Shehri MM
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):328-36. PubMed ID: 17681871
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a HPLC method for the analysis of promethazine hydrochloride in hot-melt extruded dosage forms.
Thumma S; Zhang SQ; Repka MA
Pharmazie; 2008 Aug; 63(8):562-7. PubMed ID: 18771002
[TBL] [Abstract][Full Text] [Related]
11. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets.
Mohammadi A; Rezanour N; Ansari Dogaheh M; Ghorbani Bidkorbeh F; Hashem M; Walker RB
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):215-21. PubMed ID: 17010681
[TBL] [Abstract][Full Text] [Related]
12. High performance liquid chromatographic analysis of dehydroepiandrosterone and its pharmaceutical tablet formulation.
Aboul-Enein HY
Biomed Chromatogr; 2004 Jan; 18(1):6-9. PubMed ID: 14872542
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a HPLC-UV method for the determination in didanosine tablets.
de Oliveira AM; Löwen TC; Cabral LM; dos Santos EM; Rodrigues CR; Castro HC; dos Santos TC
J Pharm Biomed Anal; 2005 Jul; 38(4):751-6. PubMed ID: 15967304
[TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a high-performance liquid chromatographic method for the determination of buspirone in pharmaceutical preparations.
Zaxariou M; Panderi I
J Pharm Biomed Anal; 2004 Apr; 35(1):41-50. PubMed ID: 15030878
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms.
Hadad GM; Emara S; Mahmoud WM
Talanta; 2009 Oct; 79(5):1360-7. PubMed ID: 19635371
[TBL] [Abstract][Full Text] [Related]
17. A novel validated LC method for quantitation of lopinavir in bulk drug and pharmaceutical formulation in the presence of its potential impurities and degradation products.
Seshachalam U; Haribabu B; Chandrasekhar K
Biomed Chromatogr; 2007 Jul; 21(7):716-23. PubMed ID: 17370253
[TBL] [Abstract][Full Text] [Related]
18. Riluzole: validation of stability-indicating HPLC, D1 and DD1 spectrophotometric assays.
Saleh OA; El-Azzouny AA; Aboul-Enein HY; Badawey AM
J Chromatogr Sci; 2014 Jul; 52(6):539-46. PubMed ID: 23744878
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
[TBL] [Abstract][Full Text] [Related]
20. A validated RP-HPLC method for the determination of mosapride citrate in bulk drug samples and pharmaceutical formulations.
Krishnaiah YS; Murthy TK; Sankar DG; Satyanarayana V
Pharmazie; 2002 Dec; 57(12):814-6. PubMed ID: 12561242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
